Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.
Akston Biosciences's investors include Propel(X), EQx Fund, Cherrystone Angel Group, National Institute of Diabetes and Digestive and Kidney Diseases, Angel Healthcare Investors.
Akston Biosciences is headquartered in Beverly, United States.
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.
Akston Biosciences is at the Series H stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Akston Biosciences — Funding & Investors." VCBacked, April 30, 2025, https://www.vcbacked.co/company/akston-biosciences. Accessed October 1, 2026.
VCBacked. (2025). Akston Biosciences — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/akston-biosciences
{{cite web |title=Akston Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/akston-biosciences |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated